DR4 Peptide
Product Specifications
NCBI Gene ID
8797
Swiss Prot
O00220
Accession Number
AAC51226
Type
Peptides
Concentration
200 ug/mL
Buffer
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Shipping Conditions
Blue Ice
Storage Conditions
Store DR4 peptide at -20˚ C, stable for one year.
Applications Notes
DR4 peptide is used for blocking the activity of DR4 antibody.
NCBI Official Name
Tumor necrosis factor receptor superfamily, member 10a
NCBI Organism
Homo sapiens
Background Reference 01
Pan G; O'Rourke K; Chinnaiyan AM; O'Rourke K; Gentz R; Ebner R; Ni J; Dixit VM. The receptor for the cytotoxic ligand TRAIL. Science; 1997;276:111-113
Background Reference 02
Background Reference 03
Peschon JJ, Slack JL, Reddy P, et al. An essential role for ectodomain shedding in mammalian development. Science 1998;282:1281-4
Other Product Names
DR4, APO2, CD261, TRAILR1, TRAILR-1, DR4, Tumor necrosis factor receptor superfamily member 10A, Death receptor 4, TRAIL receptor 1
Tested Applications
Blocking
Species
Human
Protein ID
1945072
Physical Properties
Liquid
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
EXOSC10 (Exosome Component 10, Autoantigen PM/Scl 2, P100 Polymyositis-scleroderma Overlap Syndrome-associated Autoantigen, Polymyositis/Scleroderma Autoantigen 100kD, PM/Scl-100, Polymyositis/Scleroderma Autoantigen 2, PMSCL, PMSCL2, RRP6) (MaxLight 750)
EXOSC10 (Exosome Component 10, Autoantigen PM/Scl 2, P100 Polymyositis-scleroderma Overlap Syndrome-associated Autoantigen, Polymyositis/Scleroderma Autoantigen 100kD, PM/Scl-100, Polymyositis/Scleroderma Autoantigen 2, PMSCL, PMSCL2, RRP6) (MaxLight 750)
